MRNS   $0.55  0.09% Market Open

Marinus Pharmaceuticals, Inc.
Total Cash 64.68M
totalCashPerShare 1.174
EBITDA -128.66M
Total Debt 95.89M
quickRatio 1.899
currentRatio 2.283
Total Revenue 30.26M
debtToEquity
Revenue/Share 0.539
ROA -0.57751
ROE -29.86552
grossProfits
freeCashflow -66.13M
operatingCashflow -120.47M
earningsGrowth
revenueGrowth 0.325
grossMargins -2.21928
ebitdaMargins 0.0
operatingMargins -3.75943
profitMargins 0.0
enterpriseValue 49.07M
forwardPE -0.463
floatShares 37.39M
sharesOutstanding 55.08M
sharesShort 3.49M
sharesShortPriorMonth 2.90M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.85%
Short Ratio help_outline 4.89%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue -0.861
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -149.24M
trailingEps -2.66%
forwardEps -0.70%
enterpriseToEbitda -0.38
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.41 3Q 2024
institutionsCount 110
lastUpdated Nov. 6, 2024, 5:26 p.m.